 |
Matter handles Abpro, a biotechnology company that develops antibody therapies to treat cancers, as it merges with Atlantic Coastal Acquisition Corp. in a SPAC deal worth $725M.
Ian Chan, CEO & co-founder of Abpro, said the SPAC represents a milestone for the Woburn, MA-based company.
Proceeds from the transaction will help “accelerate the advancement of our pipeline toward clinical trials and provide the foundation for ongoing development of novel immunotherapies to help patients,” said Chan.
Abpro is currently in the developmental stage with its HER2+ treatments for breast, gastric and colorectal cancers.
It also has a partnership with South Korea’s Celltrion pharmaceutical company. Celltrion has made an equity investment in Abpro.
The SPAC deal is expected to close in Q2 2024.
Matter’s Deanna Meservey handles Abpro.
Prosek Partners handles New York’s Tilray Brands, craft beer & cannabis operation, as it acquires BrewDog, a leading British independent beer producer in the UK, for $45M.
Brunswick Group handles Zurich Insurance as it agrees to buy UK-based Beazley specialty insurer in a deal valued at $11B.
FGS Global represents Brink’s as it agrees to acquire NCR Atleos, which relies on Collected Strategies, in a $6.6B cash & stock deal to create a leading fintech infrastructure company. (Updated)
A January article in O’Dwyer’s proposes that in 2026, the strongest financial brands will not simply tell compelling stories—they will “signal readiness.”
C Street Advisory Group is working the Chapter 11 filing of Axip Energy Services as it unloads its nearly all of its assets to deal with a heavy debt load.
